nodes	percent_of_prediction	percent_of_DWPC	metapath
Liotrix—ALB—Vismodegib—skin cancer	0.14	0.201	CbGbCtD
Liotrix—SLCO1B3—Docetaxel—skin cancer	0.119	0.171	CbGbCtD
Liotrix—ALB—Vemurafenib—skin cancer	0.111	0.159	CbGbCtD
Liotrix—CYP2C8—Vismodegib—skin cancer	0.108	0.155	CbGbCtD
Liotrix—ABCB1—Vismodegib—skin cancer	0.0732	0.105	CbGbCtD
Liotrix—ALB—Fluorouracil—skin cancer	0.0497	0.0713	CbGbCtD
Liotrix—ABCB1—Dactinomycin—skin cancer	0.0384	0.0551	CbGbCtD
Liotrix—CYP2C8—Fluorouracil—skin cancer	0.0384	0.0551	CbGbCtD
Liotrix—ABCB1—Docetaxel—skin cancer	0.0198	0.0285	CbGbCtD
Liotrix—SERPINA7—neck—skin cancer	0.00607	0.0807	CbGeAlD
Liotrix—SLCO4C1—nipple—skin cancer	0.00395	0.0526	CbGeAlD
Liotrix—THRB—neck—skin cancer	0.00375	0.0499	CbGeAlD
Liotrix—THRA—neck—skin cancer	0.00375	0.0499	CbGeAlD
Liotrix—SLC16A2—neck—skin cancer	0.0034	0.0452	CbGeAlD
Liotrix—TTR—neck—skin cancer	0.00279	0.0371	CbGeAlD
Liotrix—THRA—connective tissue—skin cancer	0.00269	0.0357	CbGeAlD
Liotrix—SLCO4A1—nipple—skin cancer	0.00253	0.0336	CbGeAlD
Liotrix—SLCO4C1—mammalian vulva—skin cancer	0.00231	0.0307	CbGeAlD
Liotrix—SLC16A10—nipple—skin cancer	0.00222	0.0294	CbGeAlD
Liotrix—SLC16A10—neck—skin cancer	0.00219	0.0291	CbGeAlD
Liotrix—TTR—connective tissue—skin cancer	0.002	0.0266	CbGeAlD
Liotrix—THRA—female reproductive system—skin cancer	0.0019	0.0252	CbGeAlD
Liotrix—THRB—female reproductive system—skin cancer	0.0019	0.0252	CbGeAlD
Liotrix—SLC10A1—female reproductive system—skin cancer	0.00168	0.0223	CbGeAlD
Liotrix—THRB—head—skin cancer	0.00158	0.0211	CbGeAlD
Liotrix—THRA—head—skin cancer	0.00158	0.0211	CbGeAlD
Liotrix—SLC16A10—epithelium—skin cancer	0.00149	0.0198	CbGeAlD
Liotrix—SLCO4A1—mammalian vulva—skin cancer	0.00148	0.0196	CbGeAlD
Liotrix—TTR—lymphoid tissue—skin cancer	0.00146	0.0194	CbGeAlD
Liotrix—SLC16A2—head—skin cancer	0.00144	0.0191	CbGeAlD
Liotrix—TTR—female reproductive system—skin cancer	0.00141	0.0187	CbGeAlD
Liotrix—SLC10A1—head—skin cancer	0.0014	0.0186	CbGeAlD
Liotrix—SLCO1C1—head—skin cancer	0.00132	0.0175	CbGeAlD
Liotrix—SLC16A10—mammalian vulva—skin cancer	0.00129	0.0172	CbGeAlD
Liotrix—SLCO4A1—female reproductive system—skin cancer	0.00126	0.0168	CbGeAlD
Liotrix—TTR—head—skin cancer	0.00118	0.0156	CbGeAlD
Liotrix—SLC16A10—lymphoid tissue—skin cancer	0.00115	0.0153	CbGeAlD
Liotrix—SLCO1B1—female reproductive system—skin cancer	0.00111	0.0148	CbGeAlD
Liotrix—THRB—lymph node—skin cancer	0.00111	0.0147	CbGeAlD
Liotrix—THRA—lymph node—skin cancer	0.00111	0.0147	CbGeAlD
Liotrix—SLC16A10—female reproductive system—skin cancer	0.00111	0.0147	CbGeAlD
Liotrix—SLCO4A1—head—skin cancer	0.00106	0.014	CbGeAlD
Liotrix—SLC16A2—lymph node—skin cancer	0.00101	0.0134	CbGeAlD
Liotrix—SLCO1C1—lymph node—skin cancer	0.000922	0.0123	CbGeAlD
Liotrix—Affect lability—Temozolomide—skin cancer	0.000853	0.00375	CcSEcCtD
Liotrix—Rash—Vismodegib—skin cancer	0.000851	0.00374	CcSEcCtD
Liotrix—Dermatitis—Vismodegib—skin cancer	0.00085	0.00373	CcSEcCtD
Liotrix—ABCB1—blood vessel—skin cancer	0.000838	0.0111	CbGeAlD
Liotrix—Anaphylactic shock—Vemurafenib—skin cancer	0.000834	0.00366	CcSEcCtD
Liotrix—Dysphagia—Dactinomycin—skin cancer	0.000829	0.00364	CcSEcCtD
Liotrix—Infection—Vemurafenib—skin cancer	0.000828	0.00364	CcSEcCtD
Liotrix—Mood swings—Temozolomide—skin cancer	0.000821	0.00361	CcSEcCtD
Liotrix—Cardiac failure—Fluorouracil—skin cancer	0.000819	0.00359	CcSEcCtD
Liotrix—Dehydration—Temozolomide—skin cancer	0.000806	0.00354	CcSEcCtD
Liotrix—Weight decreased—Bleomycin—skin cancer	0.000804	0.00353	CcSEcCtD
Liotrix—Nausea—Vismodegib—skin cancer	0.000802	0.00352	CcSEcCtD
Liotrix—Agitation—Imiquimod—skin cancer	0.000801	0.00352	CcSEcCtD
Liotrix—Angioedema—Imiquimod—skin cancer	0.000796	0.0035	CcSEcCtD
Liotrix—Hypokalaemia—Temozolomide—skin cancer	0.000789	0.00346	CcSEcCtD
Liotrix—Syncope—Imiquimod—skin cancer	0.000781	0.00343	CcSEcCtD
Liotrix—Acute coronary syndrome—Bleomycin—skin cancer	0.000781	0.00343	CcSEcCtD
Liotrix—Hypotension—Vemurafenib—skin cancer	0.000779	0.00342	CcSEcCtD
Liotrix—Myocardial infarction—Bleomycin—skin cancer	0.000777	0.00341	CcSEcCtD
Liotrix—Palpitations—Imiquimod—skin cancer	0.00077	0.00338	CcSEcCtD
Liotrix—Loss of consciousness—Imiquimod—skin cancer	0.000766	0.00336	CcSEcCtD
Liotrix—Muscular weakness—Temozolomide—skin cancer	0.000765	0.00336	CcSEcCtD
Liotrix—Irritability—Fluorouracil—skin cancer	0.000763	0.00335	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.00076	0.00334	CcSEcCtD
Liotrix—Cardiac arrest—Fluorouracil—skin cancer	0.00076	0.00334	CcSEcCtD
Liotrix—SLCO1A2—head—skin cancer	0.000756	0.01	CbGeAlD
Liotrix—Convulsion—Imiquimod—skin cancer	0.000755	0.00331	CcSEcCtD
Liotrix—Abdominal distension—Temozolomide—skin cancer	0.000754	0.00331	CcSEcCtD
Liotrix—Fluid retention—Docetaxel—skin cancer	0.000754	0.00331	CcSEcCtD
Liotrix—Hypertension—Imiquimod—skin cancer	0.000752	0.0033	CcSEcCtD
Liotrix—Dysphagia—Temozolomide—skin cancer	0.000749	0.00329	CcSEcCtD
Liotrix—Chest pain—Imiquimod—skin cancer	0.000742	0.00326	CcSEcCtD
Liotrix—Arthralgia—Imiquimod—skin cancer	0.000742	0.00326	CcSEcCtD
Liotrix—Anxiety—Imiquimod—skin cancer	0.000739	0.00325	CcSEcCtD
Liotrix—SLCO4A1—lymph node—skin cancer	0.000739	0.00982	CbGeAlD
Liotrix—Sweating increased—Temozolomide—skin cancer	0.00073	0.00321	CcSEcCtD
Liotrix—Decreased appetite—Vemurafenib—skin cancer	0.000725	0.00318	CcSEcCtD
Liotrix—SLC22A8—head—skin cancer	0.000722	0.00959	CbGeAlD
Liotrix—Bronchitis—Temozolomide—skin cancer	0.000721	0.00316	CcSEcCtD
Liotrix—Fatigue—Vemurafenib—skin cancer	0.000719	0.00316	CcSEcCtD
Liotrix—Constipation—Vemurafenib—skin cancer	0.000713	0.00313	CcSEcCtD
Liotrix—Oedema—Imiquimod—skin cancer	0.000711	0.00312	CcSEcCtD
Liotrix—Lightheadedness—Docetaxel—skin cancer	0.000711	0.00312	CcSEcCtD
Liotrix—Hypoaesthesia—Bleomycin—skin cancer	0.000708	0.00311	CcSEcCtD
Liotrix—Infection—Imiquimod—skin cancer	0.000707	0.0031	CcSEcCtD
Liotrix—Muscular weakness—Fluorouracil—skin cancer	0.000705	0.00309	CcSEcCtD
Liotrix—Shock—Imiquimod—skin cancer	0.0007	0.00307	CcSEcCtD
Liotrix—Tachycardia—Imiquimod—skin cancer	0.000694	0.00305	CcSEcCtD
Liotrix—Dysphagia—Fluorouracil—skin cancer	0.000691	0.00303	CcSEcCtD
Liotrix—Sepsis—Docetaxel—skin cancer	0.000689	0.00303	CcSEcCtD
Liotrix—Hyperhidrosis—Imiquimod—skin cancer	0.000688	0.00302	CcSEcCtD
Liotrix—Weight decreased—Temozolomide—skin cancer	0.000678	0.00298	CcSEcCtD
Liotrix—Anorexia—Imiquimod—skin cancer	0.000678	0.00298	CcSEcCtD
Liotrix—Angina pectoris—Fluorouracil—skin cancer	0.000673	0.00295	CcSEcCtD
Liotrix—Phlebitis—Docetaxel—skin cancer	0.000669	0.00294	CcSEcCtD
Liotrix—Flushing—Bleomycin—skin cancer	0.00066	0.0029	CcSEcCtD
Liotrix—Body temperature increased—Vemurafenib—skin cancer	0.000659	0.00289	CcSEcCtD
Liotrix—Swelling—Docetaxel—skin cancer	0.000654	0.00287	CcSEcCtD
Liotrix—SLC16A10—lymph node—skin cancer	0.000648	0.00861	CbGeAlD
Liotrix—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000648	0.00284	CcSEcCtD
Liotrix—Insomnia—Imiquimod—skin cancer	0.000643	0.00282	CcSEcCtD
Liotrix—Paraesthesia—Imiquimod—skin cancer	0.000639	0.0028	CcSEcCtD
Liotrix—Cardiac failure congestive—Docetaxel—skin cancer	0.000636	0.00279	CcSEcCtD
Liotrix—Dyspnoea—Imiquimod—skin cancer	0.000634	0.00278	CcSEcCtD
Liotrix—CYP2C8—female reproductive system—skin cancer	0.000632	0.0084	CbGeAlD
Liotrix—Alopecia—Bleomycin—skin cancer	0.000628	0.00276	CcSEcCtD
Liotrix—Decreased appetite—Imiquimod—skin cancer	0.000618	0.00271	CcSEcCtD
Liotrix—Flushing—Dactinomycin—skin cancer	0.000616	0.0027	CcSEcCtD
Liotrix—Hypersensitivity—Vemurafenib—skin cancer	0.000614	0.0027	CcSEcCtD
Liotrix—Fatigue—Imiquimod—skin cancer	0.000613	0.00269	CcSEcCtD
Liotrix—Acute coronary syndrome—Fluorouracil—skin cancer	0.000607	0.00266	CcSEcCtD
Liotrix—Renal impairment—Docetaxel—skin cancer	0.000606	0.00266	CcSEcCtD
Liotrix—Myocardial infarction—Fluorouracil—skin cancer	0.000604	0.00265	CcSEcCtD
Liotrix—Asthenia—Vemurafenib—skin cancer	0.000598	0.00263	CcSEcCtD
Liotrix—Hypoaesthesia—Temozolomide—skin cancer	0.000597	0.00262	CcSEcCtD
Liotrix—Cardiac failure—Docetaxel—skin cancer	0.000591	0.00259	CcSEcCtD
Liotrix—Pruritus—Vemurafenib—skin cancer	0.00059	0.00259	CcSEcCtD
Liotrix—Alopecia—Dactinomycin—skin cancer	0.000586	0.00257	CcSEcCtD
Liotrix—Feeling abnormal—Imiquimod—skin cancer	0.000586	0.00257	CcSEcCtD
Liotrix—Gastrointestinal pain—Imiquimod—skin cancer	0.000582	0.00255	CcSEcCtD
Liotrix—Diarrhoea—Vemurafenib—skin cancer	0.000571	0.00251	CcSEcCtD
Liotrix—Urticaria—Imiquimod—skin cancer	0.000565	0.00248	CcSEcCtD
Liotrix—Body temperature increased—Imiquimod—skin cancer	0.000562	0.00247	CcSEcCtD
Liotrix—Abdominal pain—Imiquimod—skin cancer	0.000562	0.00247	CcSEcCtD
Liotrix—Flushing—Temozolomide—skin cancer	0.000557	0.00244	CcSEcCtD
Liotrix—Dizziness—Vemurafenib—skin cancer	0.000551	0.00242	CcSEcCtD
Liotrix—Hypoaesthesia—Fluorouracil—skin cancer	0.00055	0.00241	CcSEcCtD
Liotrix—Dehydration—Docetaxel—skin cancer	0.000536	0.00235	CcSEcCtD
Liotrix—Vomiting—Vemurafenib—skin cancer	0.00053	0.00233	CcSEcCtD
Liotrix—Alopecia—Temozolomide—skin cancer	0.00053	0.00233	CcSEcCtD
Liotrix—Chest pain—Bleomycin—skin cancer	0.000527	0.00231	CcSEcCtD
Liotrix—ALB—lymph node—skin cancer	0.000526	0.00699	CbGeAlD
Liotrix—Rash—Vemurafenib—skin cancer	0.000526	0.00231	CcSEcCtD
Liotrix—Dermatitis—Vemurafenib—skin cancer	0.000525	0.00231	CcSEcCtD
Liotrix—Hypersensitivity—Imiquimod—skin cancer	0.000524	0.0023	CcSEcCtD
Liotrix—Headache—Vemurafenib—skin cancer	0.000522	0.00229	CcSEcCtD
Liotrix—Dysgeusia—Temozolomide—skin cancer	0.000511	0.00225	CcSEcCtD
Liotrix—Asthenia—Imiquimod—skin cancer	0.00051	0.00224	CcSEcCtD
Liotrix—Confusional state—Bleomycin—skin cancer	0.000509	0.00224	CcSEcCtD
Liotrix—Anaphylactic shock—Bleomycin—skin cancer	0.000505	0.00222	CcSEcCtD
Liotrix—Oedema—Bleomycin—skin cancer	0.000505	0.00222	CcSEcCtD
Liotrix—Pruritus—Imiquimod—skin cancer	0.000503	0.00221	CcSEcCtD
Liotrix—Infection—Bleomycin—skin cancer	0.000502	0.0022	CcSEcCtD
Liotrix—Dysphagia—Docetaxel—skin cancer	0.000498	0.00219	CcSEcCtD
Liotrix—Nausea—Vemurafenib—skin cancer	0.000495	0.00217	CcSEcCtD
Liotrix—Arrhythmia—Fluorouracil—skin cancer	0.000494	0.00217	CcSEcCtD
Liotrix—Vision blurred—Temozolomide—skin cancer	0.000492	0.00216	CcSEcCtD
Liotrix—Bronchospasm—Docetaxel—skin cancer	0.00049	0.00215	CcSEcCtD
Liotrix—Tremor—Temozolomide—skin cancer	0.000489	0.00215	CcSEcCtD
Liotrix—Alopecia—Fluorouracil—skin cancer	0.000488	0.00214	CcSEcCtD
Liotrix—Diarrhoea—Imiquimod—skin cancer	0.000487	0.00214	CcSEcCtD
Liotrix—Angina pectoris—Docetaxel—skin cancer	0.000485	0.00213	CcSEcCtD
Liotrix—Anorexia—Bleomycin—skin cancer	0.000482	0.00211	CcSEcCtD
Liotrix—Agitation—Temozolomide—skin cancer	0.00048	0.00211	CcSEcCtD
Liotrix—Angioedema—Temozolomide—skin cancer	0.000477	0.00209	CcSEcCtD
Liotrix—Hypotension—Bleomycin—skin cancer	0.000472	0.00207	CcSEcCtD
Liotrix—Oedema—Dactinomycin—skin cancer	0.000471	0.00207	CcSEcCtD
Liotrix—Dizziness—Imiquimod—skin cancer	0.00047	0.00206	CcSEcCtD
Liotrix—Infection—Dactinomycin—skin cancer	0.000468	0.00206	CcSEcCtD
Liotrix—Palpitations—Temozolomide—skin cancer	0.000461	0.00203	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Bleomycin—skin cancer	0.00046	0.00202	CcSEcCtD
Liotrix—Paraesthesia—Bleomycin—skin cancer	0.000454	0.00199	CcSEcCtD
Liotrix—Vision blurred—Fluorouracil—skin cancer	0.000453	0.00199	CcSEcCtD
Liotrix—Convulsion—Temozolomide—skin cancer	0.000452	0.00199	CcSEcCtD
Liotrix—Vomiting—Imiquimod—skin cancer	0.000452	0.00199	CcSEcCtD
Liotrix—Weight decreased—Docetaxel—skin cancer	0.000451	0.00198	CcSEcCtD
Liotrix—Hypertension—Temozolomide—skin cancer	0.000451	0.00198	CcSEcCtD
Liotrix—Dyspnoea—Bleomycin—skin cancer	0.00045	0.00198	CcSEcCtD
Liotrix—Anorexia—Dactinomycin—skin cancer	0.000449	0.00197	CcSEcCtD
Liotrix—Rash—Imiquimod—skin cancer	0.000448	0.00197	CcSEcCtD
Liotrix—Dermatitis—Imiquimod—skin cancer	0.000448	0.00197	CcSEcCtD
Liotrix—Headache—Imiquimod—skin cancer	0.000446	0.00196	CcSEcCtD
Liotrix—Arthralgia—Temozolomide—skin cancer	0.000445	0.00195	CcSEcCtD
Liotrix—Anxiety—Temozolomide—skin cancer	0.000443	0.00195	CcSEcCtD
Liotrix—Decreased appetite—Bleomycin—skin cancer	0.000439	0.00193	CcSEcCtD
Liotrix—Acute coronary syndrome—Docetaxel—skin cancer	0.000438	0.00192	CcSEcCtD
Liotrix—Renal failure—Docetaxel—skin cancer	0.000437	0.00192	CcSEcCtD
Liotrix—Myocardial infarction—Docetaxel—skin cancer	0.000436	0.00191	CcSEcCtD
Liotrix—Confusional state—Temozolomide—skin cancer	0.00043	0.00189	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000429	0.00188	CcSEcCtD
Liotrix—Anaphylactic shock—Temozolomide—skin cancer	0.000426	0.00187	CcSEcCtD
Liotrix—Oedema—Temozolomide—skin cancer	0.000426	0.00187	CcSEcCtD
Liotrix—Infection—Temozolomide—skin cancer	0.000423	0.00186	CcSEcCtD
Liotrix—Nausea—Imiquimod—skin cancer	0.000422	0.00185	CcSEcCtD
Liotrix—Convulsion—Fluorouracil—skin cancer	0.000417	0.00183	CcSEcCtD
Liotrix—Feeling abnormal—Bleomycin—skin cancer	0.000416	0.00183	CcSEcCtD
Liotrix—Hyperhidrosis—Temozolomide—skin cancer	0.000412	0.00181	CcSEcCtD
Liotrix—Chest pain—Fluorouracil—skin cancer	0.00041	0.0018	CcSEcCtD
Liotrix—Decreased appetite—Dactinomycin—skin cancer	0.00041	0.0018	CcSEcCtD
Liotrix—ABCB1—epithelium—skin cancer	0.000408	0.00542	CbGeAlD
Liotrix—Fatigue—Dactinomycin—skin cancer	0.000406	0.00178	CcSEcCtD
Liotrix—Anorexia—Temozolomide—skin cancer	0.000406	0.00178	CcSEcCtD
Liotrix—Urticaria—Bleomycin—skin cancer	0.000401	0.00176	CcSEcCtD
Liotrix—Body temperature increased—Bleomycin—skin cancer	0.000399	0.00175	CcSEcCtD
Liotrix—Hypoaesthesia—Docetaxel—skin cancer	0.000397	0.00174	CcSEcCtD
Liotrix—Confusional state—Fluorouracil—skin cancer	0.000396	0.00174	CcSEcCtD
Liotrix—Anaphylactic shock—Fluorouracil—skin cancer	0.000393	0.00172	CcSEcCtD
Liotrix—Oedema—Fluorouracil—skin cancer	0.000393	0.00172	CcSEcCtD
Liotrix—Infection—Fluorouracil—skin cancer	0.00039	0.00171	CcSEcCtD
Liotrix—Feeling abnormal—Dactinomycin—skin cancer	0.000388	0.0017	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000388	0.0017	CcSEcCtD
Liotrix—Insomnia—Temozolomide—skin cancer	0.000385	0.00169	CcSEcCtD
Liotrix—Gastrointestinal pain—Dactinomycin—skin cancer	0.000385	0.00169	CcSEcCtD
Liotrix—Tachycardia—Fluorouracil—skin cancer	0.000383	0.00168	CcSEcCtD
Liotrix—Paraesthesia—Temozolomide—skin cancer	0.000383	0.00168	CcSEcCtD
Liotrix—Dyspnoea—Temozolomide—skin cancer	0.00038	0.00167	CcSEcCtD
Liotrix—Anorexia—Fluorouracil—skin cancer	0.000374	0.00164	CcSEcCtD
Liotrix—Abdominal pain—Dactinomycin—skin cancer	0.000372	0.00164	CcSEcCtD
Liotrix—Body temperature increased—Dactinomycin—skin cancer	0.000372	0.00164	CcSEcCtD
Liotrix—Hypersensitivity—Bleomycin—skin cancer	0.000372	0.00163	CcSEcCtD
Liotrix—Decreased appetite—Temozolomide—skin cancer	0.00037	0.00163	CcSEcCtD
Liotrix—Flushing—Docetaxel—skin cancer	0.00037	0.00163	CcSEcCtD
Liotrix—Fatigue—Temozolomide—skin cancer	0.000367	0.00161	CcSEcCtD
Liotrix—Hypotension—Fluorouracil—skin cancer	0.000367	0.00161	CcSEcCtD
Liotrix—Constipation—Temozolomide—skin cancer	0.000364	0.0016	CcSEcCtD
Liotrix—Asthenia—Bleomycin—skin cancer	0.000362	0.00159	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000358	0.00157	CcSEcCtD
Liotrix—Pruritus—Bleomycin—skin cancer	0.000357	0.00157	CcSEcCtD
Liotrix—Arrhythmia—Docetaxel—skin cancer	0.000356	0.00156	CcSEcCtD
Liotrix—Insomnia—Fluorouracil—skin cancer	0.000355	0.00156	CcSEcCtD
Liotrix—ABCB1—mammalian vulva—skin cancer	0.000354	0.0047	CbGeAlD
Liotrix—Paraesthesia—Fluorouracil—skin cancer	0.000353	0.00155	CcSEcCtD
Liotrix—Alopecia—Docetaxel—skin cancer	0.000353	0.00155	CcSEcCtD
Liotrix—Feeling abnormal—Temozolomide—skin cancer	0.000351	0.00154	CcSEcCtD
Liotrix—Dyspnoea—Fluorouracil—skin cancer	0.00035	0.00154	CcSEcCtD
Liotrix—Gastrointestinal pain—Temozolomide—skin cancer	0.000348	0.00153	CcSEcCtD
Liotrix—Hypersensitivity—Dactinomycin—skin cancer	0.000347	0.00152	CcSEcCtD
Liotrix—Decreased appetite—Fluorouracil—skin cancer	0.000341	0.0015	CcSEcCtD
Liotrix—Dysgeusia—Docetaxel—skin cancer	0.00034	0.00149	CcSEcCtD
Liotrix—Urticaria—Temozolomide—skin cancer	0.000339	0.00149	CcSEcCtD
Liotrix—Asthenia—Dactinomycin—skin cancer	0.000338	0.00148	CcSEcCtD
Liotrix—Abdominal pain—Temozolomide—skin cancer	0.000337	0.00148	CcSEcCtD
Liotrix—Body temperature increased—Temozolomide—skin cancer	0.000337	0.00148	CcSEcCtD
Liotrix—Feeling abnormal—Fluorouracil—skin cancer	0.000324	0.00142	CcSEcCtD
Liotrix—Diarrhoea—Dactinomycin—skin cancer	0.000322	0.00142	CcSEcCtD
Liotrix—Vomiting—Bleomycin—skin cancer	0.000321	0.00141	CcSEcCtD
Liotrix—Rash—Bleomycin—skin cancer	0.000319	0.0014	CcSEcCtD
Liotrix—Dermatitis—Bleomycin—skin cancer	0.000318	0.0014	CcSEcCtD
Liotrix—ABCB1—lymphoid tissue—skin cancer	0.000314	0.00418	CbGeAlD
Liotrix—Hypersensitivity—Temozolomide—skin cancer	0.000314	0.00138	CcSEcCtD
Liotrix—Urticaria—Fluorouracil—skin cancer	0.000312	0.00137	CcSEcCtD
Liotrix—Syncope—Docetaxel—skin cancer	0.000311	0.00137	CcSEcCtD
Liotrix—Body temperature increased—Fluorouracil—skin cancer	0.00031	0.00136	CcSEcCtD
Liotrix—Palpitations—Docetaxel—skin cancer	0.000307	0.00135	CcSEcCtD
Liotrix—Asthenia—Temozolomide—skin cancer	0.000306	0.00134	CcSEcCtD
Liotrix—Loss of consciousness—Docetaxel—skin cancer	0.000305	0.00134	CcSEcCtD
Liotrix—ABCB1—female reproductive system—skin cancer	0.000303	0.00403	CbGeAlD
Liotrix—Pruritus—Temozolomide—skin cancer	0.000302	0.00132	CcSEcCtD
Liotrix—Convulsion—Docetaxel—skin cancer	0.000301	0.00132	CcSEcCtD
Liotrix—Nausea—Bleomycin—skin cancer	0.0003	0.00132	CcSEcCtD
Liotrix—Hypertension—Docetaxel—skin cancer	0.0003	0.00132	CcSEcCtD
Liotrix—Vomiting—Dactinomycin—skin cancer	0.0003	0.00132	CcSEcCtD
Liotrix—Rash—Dactinomycin—skin cancer	0.000297	0.0013	CcSEcCtD
Liotrix—Arthralgia—Docetaxel—skin cancer	0.000296	0.0013	CcSEcCtD
Liotrix—Chest pain—Docetaxel—skin cancer	0.000296	0.0013	CcSEcCtD
Liotrix—Diarrhoea—Temozolomide—skin cancer	0.000292	0.00128	CcSEcCtD
Liotrix—Hypersensitivity—Fluorouracil—skin cancer	0.000289	0.00127	CcSEcCtD
Liotrix—Confusional state—Docetaxel—skin cancer	0.000286	0.00125	CcSEcCtD
Liotrix—Anaphylactic shock—Docetaxel—skin cancer	0.000283	0.00124	CcSEcCtD
Liotrix—Oedema—Docetaxel—skin cancer	0.000283	0.00124	CcSEcCtD
Liotrix—Dizziness—Temozolomide—skin cancer	0.000282	0.00124	CcSEcCtD
Liotrix—Infection—Docetaxel—skin cancer	0.000282	0.00124	CcSEcCtD
Liotrix—Nausea—Dactinomycin—skin cancer	0.00028	0.00123	CcSEcCtD
Liotrix—Shock—Docetaxel—skin cancer	0.000279	0.00122	CcSEcCtD
Liotrix—Pruritus—Fluorouracil—skin cancer	0.000278	0.00122	CcSEcCtD
Liotrix—Tachycardia—Docetaxel—skin cancer	0.000277	0.00121	CcSEcCtD
Liotrix—Vomiting—Temozolomide—skin cancer	0.000271	0.00119	CcSEcCtD
Liotrix—Anorexia—Docetaxel—skin cancer	0.00027	0.00119	CcSEcCtD
Liotrix—Rash—Temozolomide—skin cancer	0.000269	0.00118	CcSEcCtD
Liotrix—Diarrhoea—Fluorouracil—skin cancer	0.000269	0.00118	CcSEcCtD
Liotrix—Dermatitis—Temozolomide—skin cancer	0.000268	0.00118	CcSEcCtD
Liotrix—Headache—Temozolomide—skin cancer	0.000267	0.00117	CcSEcCtD
Liotrix—Hypotension—Docetaxel—skin cancer	0.000265	0.00116	CcSEcCtD
Liotrix—Dizziness—Fluorouracil—skin cancer	0.00026	0.00114	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000258	0.00113	CcSEcCtD
Liotrix—Insomnia—Docetaxel—skin cancer	0.000256	0.00113	CcSEcCtD
Liotrix—Paraesthesia—Docetaxel—skin cancer	0.000254	0.00112	CcSEcCtD
Liotrix—ABCB1—head—skin cancer	0.000253	0.00337	CbGeAlD
Liotrix—Nausea—Temozolomide—skin cancer	0.000253	0.00111	CcSEcCtD
Liotrix—Dyspnoea—Docetaxel—skin cancer	0.000253	0.00111	CcSEcCtD
Liotrix—Vomiting—Fluorouracil—skin cancer	0.00025	0.0011	CcSEcCtD
Liotrix—Rash—Fluorouracil—skin cancer	0.000248	0.00109	CcSEcCtD
Liotrix—Dermatitis—Fluorouracil—skin cancer	0.000247	0.00109	CcSEcCtD
Liotrix—Decreased appetite—Docetaxel—skin cancer	0.000246	0.00108	CcSEcCtD
Liotrix—Headache—Fluorouracil—skin cancer	0.000246	0.00108	CcSEcCtD
Liotrix—Fatigue—Docetaxel—skin cancer	0.000244	0.00107	CcSEcCtD
Liotrix—Constipation—Docetaxel—skin cancer	0.000242	0.00106	CcSEcCtD
Liotrix—Feeling abnormal—Docetaxel—skin cancer	0.000234	0.00103	CcSEcCtD
Liotrix—Nausea—Fluorouracil—skin cancer	0.000233	0.00102	CcSEcCtD
Liotrix—Gastrointestinal pain—Docetaxel—skin cancer	0.000232	0.00102	CcSEcCtD
Liotrix—Body temperature increased—Docetaxel—skin cancer	0.000224	0.000984	CcSEcCtD
Liotrix—Abdominal pain—Docetaxel—skin cancer	0.000224	0.000984	CcSEcCtD
Liotrix—Hypersensitivity—Docetaxel—skin cancer	0.000209	0.000917	CcSEcCtD
Liotrix—Asthenia—Docetaxel—skin cancer	0.000203	0.000893	CcSEcCtD
Liotrix—Pruritus—Docetaxel—skin cancer	0.000201	0.00088	CcSEcCtD
Liotrix—Diarrhoea—Docetaxel—skin cancer	0.000194	0.000851	CcSEcCtD
Liotrix—Dizziness—Docetaxel—skin cancer	0.000187	0.000823	CcSEcCtD
Liotrix—Vomiting—Docetaxel—skin cancer	0.00018	0.000791	CcSEcCtD
Liotrix—Rash—Docetaxel—skin cancer	0.000179	0.000785	CcSEcCtD
Liotrix—Dermatitis—Docetaxel—skin cancer	0.000179	0.000784	CcSEcCtD
Liotrix—Headache—Docetaxel—skin cancer	0.000178	0.00078	CcSEcCtD
Liotrix—ABCB1—lymph node—skin cancer	0.000177	0.00236	CbGeAlD
Liotrix—Nausea—Docetaxel—skin cancer	0.000168	0.000739	CcSEcCtD
